IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

Incyte’s JAK inhibitor cream clears second eczema trial

In both trials, significantly more patients treated with ruxolitinib cream (0.75% or 1.5%) achieved Investigator’s Global Assessment Treatment Success (IGA-TS) than patients treated with a control ... Success was defined as an IGA score of 0 (clear skin

Latest news

Sanofi indicted in France over epilepsy drug birth defects

The following year, France’s social affairs inspection agency IGAS took issue with what it said was a slow response by the health authorities and Sanofi to updating the labelling of ... IGAS has estimated that between 2006 and 2014, somewhere between
UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

investigator global assessment (IGA) response of clear or almost clear.
J&J's Tremfya filed for approval in US for psoriatic arthritis

CRP), improvement in physical function (HAQ-DI), skin clearance (IGA) and quality of life (SF-36 PCS and MCS).
Tremfya heads for filing in psoriatic arthritis

DAS-28 CRP), improvement in physical function (HAQ-DI), skin clearance (IGA), and quality of life (SF-36 PCS and MCS).
Swedish biotech Calliditas signs China licensing deal for autoimmune candidate

Nefecon is a novel oral formulation of the corticosteroid budesonide which targets the active ingredient to B cells in the lower small intestine and control the output of IgA antibodies. ... Calliditas has one competitor in the field, Omeros, which is

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

New hires at Nanoform, Leo Pharma and Calliditas

IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Hayward Medical Communications launch a new, eye-opening journal

Hayward is particularly pleased that the journal features regular columns from the International Glaucoma Association (IGA) and the Royal National Institute of Blind People (RNIB). .

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....